Arcus Biosciences Inc at Citi Global Healthcare Conference Transcript
Well, here we are, another year, another conference. So welcome to the leadership team for Arcus, very familiar faces. Terry Rosen, the CEO; Jen Jarrett COO; Thanks. And Pia, thank you. Hi, Pia. And I'm Yigal Nochomovitz. I'm biotech analyst here at Citi. We've been covering Arcus now, long time. I think it's six years? I know it's since before the pandemic.
Questions & Answers
So well, why don't we just start. Obviously, all the focus is on the renal cancer asset, although there's some optionality, obviously, in some of the other areas too we can talk about. So maybe we can just start, remind everyone what is the -- what we know about cas now? What are the key pieces of evidence that are supporting the advancement into the two Phase 3s, which you've announced and then, maybe you can talk about those designs and the goals of those? You want to start with that.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
